IBL-302, CAS [[1414455-21-2]]

Produktübersicht

• Artikelname: IBL-302, CAS [[1414455-21-2]]
• Artikelnummer: MCE-HY-157169
• Hersteller Artikelnummer: HY-157169
• Alternativnummer: MCE-HY-157169-1MG,MCE-HY-157169-5MG,MCE-HY-157169-10MG,MCE-HY-157169-25MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien
• Alternative Synonym: AMU302

Produktbeschreibung

IBL-302 (AMU302) is an orally available dual-signaling inhibitor of PIM and PI3K/AKT/mTOR with activity against breast cancer and neuroblastoma. IBL-302 demonstrated in vivo efficacy in a nude mouse xenograft model, inhibiting trastuzumab (HY-P9907) resistance challenges. IBL-302 also enhances the effects of common cytotoxic chemotherapy drugs cisplatin (HY-17394), doxorubicin (HY-15142A), and etoposide (HY-13629)[1][2][3].

Produkteigenschaften

• Molekulargewicht: 567.63
• Reinheit: 98.21
• CAS Nummer: [1414455-21-2]
• Formel: C25H18FN5O4S3
• Target-Kategorie: Akt,mTOR,PI3K,Pim

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Reference compound